Ligand Pharmaceuticals | LGND - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agenus USD 107M 16M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 8.78B 236M 2026-03
Baxter International USD 8.67B 1.15B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Enviri Corporation USD 1.45B 423M 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 35.3B 1.82B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Merck USD 297.1B 35.84B 2026-03
Pacira USD 915M 149M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Veracyte USD 2.57B 758M 2026-03